世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Type (Acute Insomnia Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia of Childhood), By Drugs (Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Competition,  2020-2030F

Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Type (Acute Insomnia Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia of Childhood), By Drugs (Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Competition, 2020-2030F


Global Insomnia Treatment Market was valued at USD 3.12 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.48% through 2030F. Global insomnia tr... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年3月28日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 185 英語

 

Summary

Global Insomnia Treatment Market was valued at USD 3.12 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.48% through 2030F. Global insomnia treatment is a multifaceted approach aimed at addressing the pervasive sleep disorder known as insomnia on a worldwide scale. Insomnia, characterized by difficulty falling asleep or staying asleep, affects millions of individuals across the globe, impacting their overall health and quality of life. The treatment of insomnia has evolved significantly in recent years, reflecting a growing awareness of its profound implications for physical and mental well-being. One of the fundamental aspects of global insomnia treatment involves education and awareness campaigns to inform the public and healthcare providers about the prevalence and consequences of insomnia. This includes disseminating information about sleep hygiene practices, lifestyle modifications, and the importance of seeking professional help when necessary. Such efforts aim to reduce the stigma associated with sleep disorders and promote early intervention.
Key Market Drivers
Rising Prevalence of Insomnia
The rising prevalence of insomnia has emerged as a significant catalyst for the growth of the global insomnia treatment industry. Insomnia, characterized by persistent difficulty falling asleep or staying asleep, has become increasingly common in today's fast-paced, digitally connected world. Stress, anxiety, lifestyle changes, and the prevalence of electronic devices that disrupt sleep patterns have all contributed to this escalating problem. According to data from the World Sleep Society, approximately 30% of adults experience short-term insomnia, while 10% suffer from chronic insomnia. This surge in insomnia cases has translated into a surge in demand for effective treatments. As more individuals experience sleep disturbances and their associated negative consequences on physical and mental health, they are turning to healthcare providers for solutions. This growing awareness of the detrimental impact of untreated insomnia has led to more individuals seeking medical attention and diagnosis, thereby driving up the number of reported cases and fueling the demand for insomnia treatment options. Also, the National Library of Medicine reports that approximately 30% of adults experience insomnia symptoms, emphasizing the urgent need for effective treatments. This growing demand has driven pharmaceutical companies and healthcare providers to develop innovative therapies and expand their offerings, fueling significant market growth.
Key Market Challenges
Underdiagnosis and Misdiagnosis
Insomnia, a prevalent sleep disorder characterized by difficulty falling or staying asleep, continues to plague millions across the globe. While the demand for effective treatments rises, the global insomnia treatment industry grapples with a significant barrier: underdiagnosis and misdiagnosis. This dual challenge not only hampers the growth of the treatment sector but also exacerbates the plight of those enduring sleepless nights.
For many, insomnia is dismissed as a mere consequence of a busy lifestyle, stress, or a transient phase. The normalization of sleepless nights has led many sufferers to overlook their symptoms, often hesitating to seek professional guidance. This pervasive attitude contributes to the vast underdiagnosis of insomnia, with numerous cases going unreported. As a result, a significant portion of the population remains deprived of appropriate treatment, enduring the physical, psychological, and socio-economic repercussions of untreated insomnia.
Key Market Trends
Rise in Telemedicine and Remote Healthcare
The rise in telemedicine and remote healthcare has emerged as a pivotal trend boosting the global insomnia treatment industry. Insomnia, a widespread sleep disorder affecting individuals worldwide, has historically presented challenges in terms of access to specialized care. However, the advent of telemedicine and remote healthcare solutions has ushered in a new era of accessibility and convenience for those in need of insomnia treatment.
The COVID-19 pandemic played a significant role in accelerating the adoption of telemedicine across various medical specialties, including sleep medicine. As social distancing measures and lockdowns disrupted traditional healthcare delivery, patients turned to virtual consultations with sleep specialists and therapists for their insomnia-related concerns. This shift in healthcare delivery eliminated geographical barriers, enabling individuals from diverse locations to access expert guidance and treatment options for their sleep disorders.
Key Market Players
• Merck & Co
• Pfizer Inc.
• Abbott Laboratories
• Genentech Inc.
• LGM Pharma
• Sigma Aldrich Corp.
• Sanofi S.A
• Takeda Pharmaceuticals Co. Ltd.
• Eisai Ltd.
• Idorsia Pharmaceuticals Apotex Corp
Report Scope:
In this report, the Global Insomnia Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Insomnia Treatment Market, By Type:
o Acute Insomnia Chronic Insomnia
o Onset Insomnia
o Maintenance Insomnia
o Behavioral Insomnia of Childhood
• Insomnia Treatment Market, By Drugs:
o Eszopiclone
o Ramelteon
o Zaleplon
o Zolpidem
o Estazolam
o Others
• Insomnia Treatment Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Insomnia Treatment Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Insomnia Treatment Market.
Available Customizations:
Global Insomnia Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).


ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Insomnia Treatment Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Type (Acute Insomnia Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia of Childhood)
4.2.2. By Drugs (Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam, Others)
4.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
4.2.4. By Region
4.2.5. By Company (2024)
4.3. Market Map
4.3.1. By Type
4.3.2. By Drugs
4.3.3. By Distribution Channel
4.3.4. By Region
5. Asia Pacific Insomnia Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Drugs
5.2.3. By Distribution Channel
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Insomnia Treatment Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Type
5.3.1.2.2. By Drugs
5.3.1.2.3. By Distribution Channel
5.3.2. India Insomnia Treatment Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Type
5.3.2.2.2. By Drugs
5.3.2.2.3. By Distribution Channel
5.3.3. Australia Insomnia Treatment Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Type
5.3.3.2.2. By Drugs
5.3.3.2.3. By Distribution Channel
5.3.4. Japan Insomnia Treatment Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Type
5.3.4.2.2. By Drugs
5.3.4.2.3. By Distribution Channel
5.3.5. South Korea Insomnia Treatment Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Type
5.3.5.2.2. By Drugs
5.3.5.2.3. By Distribution Channel
6. Europe Insomnia Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Drugs
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Insomnia Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Drugs
6.3.1.2.3. By Distribution Channel
6.3.2. Germany Insomnia Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Drugs
6.3.2.2.3. By Distribution Channel
6.3.3. Spain Insomnia Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Drugs
6.3.3.2.3. By Distribution Channel
6.3.4. Italy Insomnia Treatment Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Drugs
6.3.4.2.3. By Distribution Channel
6.3.5. United Kingdom Insomnia Treatment Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Drugs
6.3.5.2.3. By Distribution Channel
7. North America Insomnia Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Drugs
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Insomnia Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Drugs
7.3.1.2.3. By Distribution Channel
7.3.2. Mexico Insomnia Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Drugs
7.3.2.2.3. By Distribution Channel
7.3.3. Canada Insomnia Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Drugs
7.3.3.2.3. By Distribution Channel
8. South America Insomnia Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Drugs
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Insomnia Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Drugs
8.3.1.2.3. By Distribution Channel
8.3.2. Argentina Insomnia Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Drugs
8.3.2.2.3. By Distribution Channel
8.3.3. Colombia Insomnia Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Drugs
8.3.3.2.3. By Distribution Channel
9. Middle East and Africa Insomnia Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Drugs
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Insomnia Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Drugs
9.3.1.2.3. By Distribution Channel
9.3.2. Saudi Arabia Insomnia Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Drugs
9.3.2.2.3. By Distribution Channel
9.3.3. UAE Insomnia Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Drugs
9.3.3.2.3. By Distribution Channel
9.3.4. Egypt Insomnia Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Drugs
9.3.4.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Insomnia Treatment Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. Merck & Co
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Pfizer Inc.
14.3. Abbott Laboratories
14.4. Genentech Inc.
14.5. LGM Pharma
14.6. Sigma Aldrich Corp.
14.7. Sanofi S.A
14.8. Takeda Pharmaceuticals Co. Ltd.
14.9. Eisai Ltd.
14.10. Idorsia Pharmaceuticals Apotex Corp
15. Strategic Recommendations
16. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

TechSci Research社のヘルスケア分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/08 10:26

148.77 円

163.31 円

192.60 円

ページTOPに戻る